PS
Therapeutic Areas
Spotlight Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AI-Powered Prognostic Assay for ER+/HER2- Early Breast Cancer | Early-stage, Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer | Validated |
| Drug | Indication | Phase |
|---|---|---|
| AI-Powered Prognostic Assay for ER+/HER2- Early Breast Cancer | Early-stage, Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer | Validated |